← Back to all trials
Active Not Recruiting
NCT05092009
Lung Cancer Organoids and Patient Derived Tumor Xenografts
Conditions: Lung Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 600
Sponsor: Maastricht Radiation Oncology
Location: Zuyderland Medical Center Heerlen
Summary
Extra tissue will be taken from patient during a procedure in standard of care. Also, through an existing line, 10ml of extra blood will be drawn. From this material the investigator will try to establish matched normal and primary human lung cancer organoids.
Eligibility Criteria
Inclusion Criteria:
* All patients selected to undergo primary surgical resection of a primary lung cancer. All types of resection are eligible, e.g. wedge resection, segmental resection, lobectomy, pneumonectomy.
* All patients with (suspected) lung cancer that will undergo a bronchoscopy or endobronchial ultrasound guided transbronchial needle aspiration (EBUS/EUS-TBNA) bronchoscopy.
Exclusion Criteria:
There are no exclusion criteria
Source: ClinicalTrials.gov (NCT05092009). StuddyBuddy aggregates publicly available trial information.
